Giorgio Giacomo Galli

17PUBLICATIONS
125CO-AUTHORS
Molecular targetsPowder and particle technologyBiologically active moleculesCarbon sequestration sciencePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

|Apr 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.

|Dec 02, 2025
Identification and characterization of binders to a cryptic and functional pocket in KRAS.

Kim S Beyer, Jessica Klein, Stéphanie Katz

|Jul 02, 2025
Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.

Zachary J Hauseman, Frédéric Stauffer, Kim S Beyer

|May 07, 2025
Targeting the SHOC2-RAS interaction in RAS-mutant cancers.

Zachary J Hauseman, Frédéric Stauffer, Kim S Beyer

|Jun 17, 2024
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Emilie A Chapeau, Laurent Sansregret, Giorgio G Galli

Pageof 3

Frequent Collaborators

6 joint publications

Luca Tordella

4 joint publications

Kim S Beyer

4 joint publications

Ulrike Naumann

3 joint publications

Daniel Guthy